Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study on Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B

NCT04028856 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT04028856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study on Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2018
Completion date
June 30, 2019
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b